Business Wire

FDA Grants 510(k) Clearance to Onera STS, a System for At-Home and In-Lab Polysomnography Studies

Share

Onera Health, a leader in transforming sleep medicine and remote monitoring, announced today that its wholly-owned subsidiary in the Netherlands, Onera B.V., has received 510(k) market clearance from the U.S. Food & Drug Administration (FDA) for its ground-breaking system for Polysomnography (PSG) studies, Onera STS, paving the way for widespread deployment of the patch-based technology across healthcare systems in the U.S. The FDA determined that Onera’s product was substantially equivalent to a system widely used in today’s in-lab PSG studies, marketed by the medical device manufacturer Natus Medical Inc.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220428005750/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Onera has received 510(k) clearance from the US Food and Drug Administration (FDA) for its innovative patch-based system for sleep studies, Onera STS (Photo: Business Wire)

Onera’s clinical-grade technology is a huge step forward in transforming the outdated, cumbersome, and expensive process of traditional sleep testing, which is partly responsible for the underdiagnosis of sleep disorders.

Achieving FDA clearance is an exciting and critical milestone to our commitment to helping our customers deliver better access to care for their patients,” says Ruben de Francisco, Founder and CEO of Onera. “The last two years caused a behavioral shift and widespread acceptance of at-home diagnostics as both patients and medical professionals sought quality solutions that deliver reliable results. Receiving the FDA 510(k) clearance demonstrates that our non-invasive, compact, and portable medical device offers the comprehensive data that is required to support the diagnosis of sleep disorders, whether at the patients’ home or in the clinic.”

Onera STS patch-based product, in combination with Onera’s Digital Health Platform, supports the company’s PSG end-to-end service that enables and simplifies clinical-grade sleep studies with no upfront investment at a fixed fee per test.

Our service helps to remove the most burdensome physical, scheduling, and financial barriers that have traditionally challenged access to professional sleep diagnosis and treatment in the past. The user-centric technology supports not only at-home diagnostics but also offers opportunities for hospitals that have limited or no access to a sleep clinic to implement sleep diagnostic testing within their institution. Our end-to-end solution has the potential to improve the sleep and ultimately overall health of millions of patients”, explains de Francisco.

Sleep disorders, such as narcolepsy or idiopathic hypersomnia, are frequently life-long conditions that can impact every facet of an individual’s life. Onera Health’s hardware and software innovations, as well as its streamlined service model, have the potential to create an important opportunity for clinicians to have a new testing and diagnostic tool for their patients to receive a quicker diagnosis and ultimately lead to optimal sleep care”, says Jed Black, M.D., senior fellow, neuroscience at Jazz Pharmaceuticals and adjunct professor, Stanford University Medical Center, Stanford Center for Sleep Sciences and Medicine.

The company stated that Onera’s end-to-end solution’s commercial launch in Europe is scheduled for the second half of the year, with plans to extend it with selected partnerships to the American market, before commercializing it broadly in 2023.

Onera Health will present its latest clinical study results at SLEEP 2022, from 4th-8th June 2022 in Charlotte, NC.

About Onera

Onera Health is a leader in transforming diagnostics and monitoring. Their breakthrough products and technologies are poised to help millions of people struggling with health ailments and chronic conditions in a variety of medical fields, including sleep, neuro, cardiac and respiratory care, ultimately improving the health and quality of life for patients around the world. The company’s innovative solutions provide comprehensive physiological and health-related data to physicians in a variety of clinical and non-clinical environments to optimize patient care and reduce healthcare costs. Onera has offices in the Netherlands and the US. For more information, go to www.onerahealth.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Swea Hagenhoff
P: +31 (0)40 3082177
E: media@onerahealth.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Aqara Launches Amazon Brand Stores in Italy and Spain17.5.2022 10:00:00 EEST | Press release

Aqara, a leading provider of smart home products, announced the debut of its brand stores on Amazon.it and Amazon.es. Since the launch of Aqara’s first European brand store on Amazon UK in July 2021, the smart home manufacturer has expanded its Amazon presence to France, Germany, Italy and Spain, making the comprehensive portfolio of Aqara products easily accessible for smart home users across Europe. Aqara has been selling in Italy and Spain on the Apple Online Store and via local retailers, and the brand has become increasingly popular among the local users for the build quality, the accessible prices and the wide compatibility with major ecosystems including HomeKit, Alexa, and Google Home. The launch of its Amazon brand stores will bring more Aqara products to the local markets, ranging from smart home hubs, smart sensors, security cameras, wired and wireless switches, to smart shade controllers. The product lineup of the Aqara brand stores on Amazon.it and Amazon.es include: Camer

BearingPoint Study: Does Your Data Underpin Resilience or Undermine It?17.5.2022 09:55:00 EEST | Press release

Management and technology consultancy BearingPoint has created a deep dive study on enterprise data resilience. This paper is the first of five companion pieces to the 2021 ‘Can you thrive under pressure’ study, the analysis of over 5,000 projects leading to the ranking of 150 best practice resilient organizations. BearingPoint has also created a resilience benchmarking tool that enables any organization to assess their own alignment with the five fundamental pillars of resilience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220516005860/en/ BearingPoint Study: Does your data underpin resilience or undermine it? Key results at a glance. BearingPoint believe data and analytic resilience is undermined by lack of people empowerment, as 65% of organizations lack data literacy and 56% face cultural resistance to change. Other obstacles impacting data led change initiatives included lack of resources and funding (33%) and disco

BforBank Chooses Temenos on Google Cloud to Power Future Expansion17.5.2022 09:30:00 EEST | Press release

Temenos (SIX: TEMN) today announced that BforBank, the fully digital bank of the Crédit Agricole Group, has selected Temenos open platform for composable banking to support future expansion. The bank is moving from an on-premise implementation to using Temenos core banking solutions on Google Cloud to tap new growth opportunities and drive efficiencies at scale. A pioneer in digital banking, BforBank launched in 2009, offering a new approach to savings, life insurance, mutual funds and e-brokerage to the French mass affluent market. The online bank has since expanded to provide a full suite of retail banking services, with accounts, payments and lending products, including mortgages. Providing a simple and highly personalized experience “empowering customers to become their own private banker” has enabled BforBank to differentiate in an increasingly competitive market. Since its inception, Temenos core banking software has underpinned the bank’s back-office operations. As banking becom

Inversago Pharma Appoints Glenn S. Vraniak as Chief Financial Officer17.5.2022 09:00:00 EEST | Press release

Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today announces the appointment of Glenn S. Vraniak to the position of Chief Financial Officer (CFO), effective immediately. Mr. Vraniak’s career spans more than 20 years of financial and commercial experience in the life sciences industry. Before joining Inversago, Mr. Vraniak served as Chief Financial Officer of Evaxion Biotech A/S, an AI enabled immuno-oncology company and led the company through a successful IPO on Nasdaq in February 2021, and successfully raised follow-on capital later that same year. Prior to that, Mr. Vraniak served as the Chief Financial Officer of electroCore, Inc. and was a key member of the management team that led the company through a successful IPO on Nasdaq in June 2018. Additionally, Mr. Vraniak served as an executive in various innovative healthcare and technology companies including GE Capital, where he served as Executive Vice Presid

Media Alert: Redwire to Open New Space Robotics Facility in Luxembourg, Minister of Economy Franz Fayot and U.S. Ambassador Thomas Barrett to Attend Ribbon-Cutting17.5.2022 09:00:00 EEST | Press release

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that it will be hosting a ribbon-cutting at its facility in Luxembourg City, Luxembourg, on May 19. There will be a tour of the laboratories, technology displays and remarks from featured speakers, including Luxembourg’s Minister of Economy Franz Fayot, U.S. Ambassador to Luxembourg Thomas Barrett and Redwire Chairman and CEO Peter Cannito. Redwire’s facility in Luxembourg designs and develops robotic arms for orbital, free-flying and lunar missions to support and enable activities such as satellite life extension, in-space assembly and manufacturing, debris removal, payload management and lunar surface operations. Participating media are invited to arrive at 18:00 at Redwire’s Luxembourg facility located at 10 Rue Henri M. Schnadt, 1811 Luxembourg. The ribbon-cutting will take place at 18:30, followed by remarks from featured speakers and a tour of the laboratories.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom